Citadel Advisors
CRXT

Citadel Advisors’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Citadel Advisors’s Portfolio CRXT Stock Details CRXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,597
Closed -$31K – 7553
2021
Q4 		$31K Buy
+12,597
New +$31K ﹤0.01% 6265